Nueclear Web Banner
Users Online: 51
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

NEURO ONCOLOGY: REVIEW ARTICLE

Recurrent Glioblastoma: Where we stand

Roy Sanjoy, Lahiri Debarshi, Maji Tapas, Biswas Jaydip

Year : 2015| Volume: 4| Issue : 4 | Page no: 163-173

   This article has been cited by
 
1 Towards an advanced cell-based in vitro glioma model system
Valeriia Mikhailova,Valeriia Gulaia,Vladlena Tiasto,Stanislav Rybtsov,Margarita Yatsunskaya,Alexander Kagansky
AIMS Genetics. 2018; 5(2): 91
[Pubmed]  [Google Scholar] [DOI]
2 Localized targeted antiangiogenic drug delivery for glioblastoma
Gregory D. Arnone,Abhiraj D. Bhimani,Tania Aguilar,Ankit I. Mehta
Journal of Neuro-Oncology. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Advances in Brain Tumor Surgery for Glioblastoma in Adults
Montserrat Lara-Velazquez,Rawan Al-Kharboosh,Stephanie Jeanneret,Carla Vazquez-Ramos,Deependra Mahato,Daryoush Tavanaiepour,Gazanfar Rahmathulla,Alfredo Quinones-Hinojosa
Brain Sciences. 2017; 7(12): 166
[Pubmed]  [Google Scholar] [DOI]
4 Validation of an established prognostic score after re-irradiation of recurrent glioma
Kerstin A. Kessel,Josefine Hesse,Christoph Straube,Claus Zimmer,Friederike Schmidt-Graf,Jürgen Schlegel,Bernhard Meyer,Stephanie E. Combs
Acta Oncologica. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection
C. Bastiancich,J. Bianco,K. Vanvarenberg,B. Ucakar,N. Joudiou,B. Gallez,G. Bastiat,F. Lagarce,V. Préat,F. Danhier
Journal of Controlled Release. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
Benxu Cheng,Liza Doreen Morales,Yonghong Zhang,Shizue Mito,Andrew Tsin,Salvatore V Pizzo
PLOS ONE. 2017; 12(9): e0184324
[Pubmed]  [Google Scholar] [DOI]
7 Randomized Trial for Short-Term Radiation Therapy With Temozolomide in Elderly Patients With Glioblastoma
David J. McCarthy,Ricardo J. Komotar,Robert M. Starke,E. Sander Connolly
Neurosurgery. 2017; 81(3): N21
[Pubmed]  [Google Scholar] [DOI]
8 A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy
Lei Yin,Heng Li,Wenjian Liu,Zhenglin Yao,Zhenzhen Cheng,Huabei Zhang,Hui Zou
European Journal of Medicinal Chemistry. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug
Sheng Zhong,Bo Wu,Xuechao Dong,Yujuan Han,Shanshan Jiang,Ying Zhang,Yang Bai,Sean X. Luo,Yong Chen,Huimao Zhang,Gang Zhao
World Neurosurgery. 2017;
[Pubmed]  [Google Scholar] [DOI]
10 Recurrent glioblastoma: a single-institution experience with reirradiation and temozolomide
Tejinder Kataria,Deepak Gupta,Ratika Gupta,Shikha Goyal,Shyam Singh Bisht,Trinanjan Basu,Ashu Abhishek,Kushal Narang,Susovan Banerjee
Journal of Radiation Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
11 Harnessing nanomedicine for therapeutic intervention in glioblastoma
Anna Gutkin,Zvi R. Cohen,Dan Peer
Expert Opinion on Drug Delivery. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article